CLRBZ
Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
CLRBZ
Delisted
CLRBZ was delisted on the 16th of April, 2021.
3 hedge funds and large institutions have $1.23M invested in Cellectar Biosciences, Inc. Series A Warrants in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$4K |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$2K |
Top Sellers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $1.23M | +$1.23M | +583,037 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $4K | +$3.57K | +26,405 | +821% |
|
|
TSS
3
Two Sigma Securities
New York
| $2K | +$2K | +14,221 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$4K | -30,498 | Closed |
|